RSVAX
Price
$24.94
Change
-$0.04 (-0.16%)
Updated
Aug 6 closing price
Net Assets
255.16M
VMVAX
Price
$86.53
Change
-$0.27 (-0.31%)
Updated
Aug 6 closing price
Net Assets
31.04B
Interact to see
Advertisement

RSVAX vs VMVAX

Header iconRSVAX vs VMVAX Comparison
Open Charts RSVAX vs VMVAXBanner chart's image
Victory RS Value A
Price$24.94
Change-$0.04 (-0.16%)
VolumeN/A
Net Assets255.16M
Vanguard Mid-Cap Value Index Admiral
Price$86.53
Change-$0.27 (-0.31%)
VolumeN/A
Net Assets31.04B
RSVAX vs VMVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSVAX vs. VMVAX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSVAX is a Buy and VMVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 31B vs. RSVAX (255M). VMVAX pays higher dividends than RSVAX: VMVAX (2.22) vs RSVAX (0.37). RSVAX was incepted earlier than VMVAX: RSVAX (32 years) vs VMVAX (14 years). RSVAX (1.33) is less costly to investors than VMVAX (0.07). RSVAX is a more actively managed with annual turnover of: 39.00 vs. VMVAX (19.00). RSVAX has a lower initial minimum investment than VMVAX: RSVAX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 9.26 vs. RSVAX (-2.68). VMVAX return over 5 years is better than : 64.27 vs. RSVAX (23.17).
RSVAXVMVAXRSVAX / VMVAX
Total Expense Ratio1.300.071,857%
Annual Report Gross Expense Ratio1.330.071,900%
Fund Existence32 years14 years-
Gain YTD0.2413.6697%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets255M31B1%
Annual Yield % from dividends0.372.2217%
Returns for 1 year-2.689.26-29%
Returns for 3 years0.9122.044%
Returns for 5 years23.1764.2736%
Returns for 10 years-21.8488.41-25%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PADEX22.490.14
+0.63%
Putnam Dynamic Asset Allocation Gr R5
ISBAX14.24N/A
N/A
VY® Columbia Contrarian Core A
FINSX49.08N/A
N/A
Fidelity Advisor New Insights I
MIRSX21.75N/A
N/A
Victory Integrity Small/Mid-Cap Value R6
FIKAX48.01N/A
N/A
Fidelity Advisor Energy Z